Glucose Monitoring Met Sensor.

Effectiveness of continuous glucose monitoring in pregnancy in women with type 1 and type 2 diabetes.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27866

Enrollment

300

Registered

2011-07-15

Start date

2011-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy, diabetes mellitus

Interventions

Patients in the intervention group will receive in addition to regular glucose assessments a continuous glucose monitoring. This will be placed every 6 weeks for 5-7 days. After every monitor cycle, t

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women with either diabetes type 1 or 2; 2. On insuline therapy; 3. Singelton pregnancies.

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancies; 2. Severe medical or psychological comorbidity.

Design outcomes

Primary

Measure	Time frame
Macrosomia: Birth weight above 90th percentile. Measured directly after birth.	—

Secondary

Measure	Time frame
1. HbA1c: Regular measurements every 6 weeks; 2. Birth weight; 3. Maternal and neonatal morbidity: Information on labour and following few days will be collected; 4. Cost-effectiveness.	—

Contacts

Public ContactD. Munster, van

Postbus 85090

GlucoMOMS@studies-obsgyn.nl+31 (0)88 7555555

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)